对比增强超声LI-RADS对肝硬化和慢性乙型肝炎患者肝细胞癌的诊断价值
回顾性分析205例高危肝细胞癌患者的单发肝结节,按CEUS LI-RADS分类比较肝硬化和慢性乙型肝炎患者的诊断效能。肝硬化和慢性乙型肝炎中LR-5类结节对应肝细胞癌的比例分别为95.8%(92/96)和61.3%(19/31),差异有统计学意义(P=0.000);LR-M类结节中非肝细胞癌恶性肿瘤在慢性乙型肝炎患者中占76.0%,高于肝硬化患者的25.0%(P=0.001)。结论认为LR-5类在肝硬化患者中对肝细胞癌诊断高度特异,但在慢性乙型肝炎患者中阳性预测值不理想,需进一步CT或MRI检查或组织学确认。
要点
- 肝硬化患者LR-5类结节对肝细胞癌的阳性预测值为95.8%(92/96)。
- 慢性乙型肝炎患者LR-5类结节对肝细胞癌的阳性预测值仅61.3%(19/31),差异有统计学意义(P=0.000)。
- 慢性乙型肝炎患者LR-M类结节中非肝细胞癌恶性肿瘤占76.0%,高于肝硬化的25.0%(P=0.001)。
核心结论
- LR-5类对肝硬化患者肝细胞癌诊断高度特异,但慢性乙型肝炎患者中LR-5类结节对肝细胞癌的阳性预测值不理想,需进一步CT或MRI检查或组织学确认。
研究设计与样本
- 回顾性分析205例高危肝细胞癌患者单发肝结节,所有患者年龄>18岁且病灶直径<50 mm,按大小及动脉期、门静脉期和延迟期对比增强模式进行CEUS LI-RADS分类,比较肝硬化和慢性乙型肝炎两组患者的诊断效能及LR-M类中非肝细胞癌恶性肿瘤比例。
诊断标准与关键数值
- 205个结节中142个(69.3%)为肝细胞癌,中位结节大小34 mm;127个(61.9%)为LR-5类,其中肝硬化患者LR-5类结节对应肝细胞癌的比例为95.8%(92/96),慢性乙型肝炎患者为61.3%(19/31),P=0.000;LR-5类对肝细胞癌的阳性预测值在肝硬化中为95.8%、在慢性乙型肝炎中为61.3%,P=0.000;LR-4类结节在肝硬化患者中证实为肝细胞癌的比例高于慢性乙型肝炎患者(80.0% vs 8.3%,P=0.000);41个LR-M类结节中,慢性乙型肝炎患者非肝细胞癌恶性肿瘤占76.0%,高于肝硬化患者的25.0%(P=0.001)。
临床应用与阅片要点
- 作者认为慢性乙型肝炎患者的LR-5类结节需进一步CT或MRI检查或组织学确认;原文未报告其他阅片要点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To explore the diagnostic value of American College of Radiology Contrast-Enhanced Ultrasound-Liver Imaging Reporting and Data System (ACR-CEUS-LI-RADS) for hepatocellular carcinoma (HCC) in patients with cirrhosis and chronic hepatitis B.
METHODS: A total of 205 patients at high risk of HCC with solitary hepatic nodule were enrolled and retrospectively analyzed. All patients were over 18 years old and had a single lesion with a diameter < 50 mm. Lesions were categorized according to size and contrast enhancement patterns in the arterial, portal venous and late phases. Diagnostic efficacy of CEUS LI-RADS for HCC, and the rate of non-HCC malignancies in the LR-M class were compared between patients with cirrhosis and chronic hepatitis B.
RESULTS: Of all 205 nodules (median nodule size was 34 mm), 142 (69.3%) were HCC. Of the 127 (61.9%) LR-5 category nodules, 95.8% (92/96) nodules were corresponded to HCC in cirrhosis, while 61.3% (19/31) nodules were corresponded to HCC in chronic hepatitis B (P = 0.000). Positive predictive value (PPV) of LR-5 category for HCC was 95.8% in cirrhosis and 61.3% in chronic hepatitis B (P = 0.000). More category of LR-4 nodules were proved to be HCC in patients with cirrhosis than chronic hepatitis B (80.0% vs 8.3%, P = 0.000). Of 41 LR-M category nodules, more non-HCC malignancies were found in chronic hepatitis B (76.0%) than that in cirrhosis (25.0%, P = 0.001).
CONCLUSIONS: The LR-5 category is highly specific for the diagnosis of HCC in patients with cirrhosis. However, LR-5 category nodules require further CT or MRI examination or histological confirmation in patients with chronic hepatitis B for its unsatisfactory PPV for HCC.
引用
- Yang, Hu, Li, et al. The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B. Abdom Radiol (NY). 2021. PMID: 34910237. doi:10.1007/s00261-021-03345-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。